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UNIT 8.1Determination of Binding Mode:
Intercalation
This unit describes several techniques that can be used to establish the role of intercalation
in the binding of small molecules to DNA. In very general terms, a molecule can be
presumed to bind to DNA by intercalation between base pairs if it causes lengthening and
unwinding of the DNA helix and undergoes changes in its spectral properties, such as
DNA-induced hypochromism and quenching of its UV absorbance. DNA lengthening
and unwinding can be determined from the change in viscosity of a solution of linear or
plasmid DNA, respectively, upon addition of ligand (see Basic Protocols 1 and 2 and
Alternate Protocols 1 and 2). Changes in the optical properties upon intercalation of the
ligand can be monitored as described in Basic Protocol 3. A Support Protocol detailing
the preparation of appropriately sized and purified DNA needed for Basic Protocols 1 and
3 and Alternate Protocol 1 is also included. If one of the above-mentioned criteria is not
satisfied, then classical intercalation cannot be assumed. Ultimately, biochemical evi-
dence for intercalation should be corroborated by nuclear magnetic resonance (NMR) or
crystallographic studies.
Of critical importance to these binding mode experiments is knowledge of the thermody-
namics of binding of the molecule to DNA. The determination of binding constants is
presented in UNIT 8.2.
BASIC
PROTOCOL 1
DETERMINATION OF DNA LENGTHENING BY VISCOMETRY
The mechanical properties of DNA require that the helix be lengthened to accommodate
the positioning of a molecule between DNA base pairs. The simplest method to measure
this lengthening is viscometry, as the viscosity of a DNA solution increases with the length
of a DNA molecule. Using a capillary viscometer suspended in a constant-temperature
water bath, the rate of flow of a solution of short DNA fragments is measured in the
absence and presence of a candidate intercalator to determine the relative change in
viscosity of the solution.
Materials
10% HNO3
10 mM buffer (Tris⋅Cl, HEPES, or other buffer) containing 1 mM EDTA, pH 7
(for TE buffer see APPENDIX 2A)
0.8 to 2.5 mM (base pairs) sonicated S1 nuclease-treated calf thymus DNA of
∼200-bp average length, in above buffer (see Support Protocol)
Ligand of interest dissolved in above buffer
Semi-micro capillary viscometer (Cannon-Ubehold or Cannon-Manning
semi-micro type 75, see Fig. 8.1.1) 
0.4-µm membrane filtration apparatus (e.g., Millipore Ultrafree MC or Centricon
filters)
Constant-temperature water bath, 25° ± 0.1°C
Stopwatch (± 0.01 sec) or Wescan fiber-optic detection unit and timer (Wescan
Instruments)
Micropipettor with extension or extended microsyringe assembly (Hamilton or
Stoelting)
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NOTE: All solutions should be passed through a 0.4-µm membrane filter to remove
particulate matter that could clog the viscometer capillary and thus produce aberrant flow
times.
Determine buffer flow time
1. Clean the viscometer overnight with 10% HNO3, rinse thoroughly with deionized
water, and dry prior to use. Place 1 mL of 10 mM buffer in a semi-micro capillary
viscometer (tube A in Fig. 8.1.1) and equilibrate to 25°C for 5 min in a constant-tem-
perature water bath.
To conserve reagents, volumes as low as 750 L can be used in certain viscometers, such
as the Cannon 75C15. Be sure to use the same volume in all determinations. 
The viscometer should remain immersed in the water bath at all times.
2. Apply gentle suction to the other end of the viscometer (tube B in Fig. 8.1.1) with a
pipet bulb and draw the buffer into the arm with the capillary until the meniscus lies
above the upper marking (etched line) on the viscometer (mark C in Fig. 8.1.1).
3. Release the suction and start the stopwatch when the meniscus reaches the upper
marking (mark C). Stop the stopwatch when the meniscus reaches the lower marking
(mark D).
Alternatively, the fiber-optic detection unit can be used to automatically determine flow
times.
4. Perform several repetitions of the flow-time determination until the flow times fall
within ±0.5 sec. Calculate the average flow time for at least three determinations.
5. Remove the buffer completely from the viscometer using a micropipettor with an
extension or a long microsyringe to withdraw the remaining droplets.
Each solution must be completely removed from the viscometer prior to the addition of the
next solution to prevent dilution of the DNA or ligand concentration.
Figure 8.1.1 Cannon-Manning semi-micro viscometer. As described in Basic Protocol 1, solution
is placed in tube A and suction is applied to tube B to draw solution above mark C. Flow time is
determined from the time it takes for the meniscus to pass from mark C to mark D.
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Optimize flow time for DNA solution
6. Prepare 1 mL of sonicated, S1 nuclease-treated calf thymus DNA at 1 mM base pairs
in buffer.
7. Dispense the solution into the viscometer and equilibrate to 25°C in the water bath
for 5 min.
8. Determine flow times as described in steps 2 to 4. Optimize the flow time by repeating
this step with varying concentrations of DNA.
The flow time should vary between 70 sec and 150 sec depending on the particular
viscometer used. The acceptable range of DNA concentrations is 0.5 to 2.5 mM base pairs.
9. Prepare a 5- to 10-mL filtered stock of the final DNA solution.
This will avoid small changes in viscosity due to pipetting errors.
Determine flow time without ligand
10. Place 1 mL of the appropriate DNA solution into the viscometer and equilibrate to
25°C.
11. Perform several repetitions of the flow-time determination (steps 2 to 4) until the
flow times fall within ±0.5 sec. Calculate the average flow time for at least three
determinations.
Determine flow time in the presence of ligand
12. Add a small, filtered aliquot of the ligand dissolved in buffer (1 to 2 µL) to the DNA
solution in the viscometer and mix the solution by repeated gentle pipetting or by
gently bubbling nitrogen through the solution. Equilibrate to 25°C for 5 min.
It is best to start with a ligand concentration that results in 3 to 10 bound ligand molecules
per 100 base pairs of DNA. This concentration can be calculated from the binding constant
determined as described in UNIT 8.2. Alternatively, a broad range of ligand concentrations
can be examined; however, this is time consuming. 
Particulate matter should be removed from the ligand solution by filtration.
13. Determine the average flow time as in steps 2 to 4.
14. Repeat steps 12 and 13 until the total added volume of ligand is no more than 15 µL.
The small dilution of DNA by added ligand will be taken into account in the calculation of
relative viscosities described shortly.
15. If additional ligand concentrations are required, rinse the viscometer with deionized
water, dry, and start with a more concentrated ligand stock and a fresh 1-mL volume
of DNA solution. Repeat steps 10 and 11, and use this flow time in subsequent
calculations of relative viscosity changes with the new ligand concentrations.
Calculate relative viscosities and analyze data
16. Calculate the specific viscosity of the DNA solution without added ligand (η0) using
the flow times of buffer without (t0) and with (t) DNA and the equation η0 = (t − t0)/t0.
17. Calculate the specific viscosity of the DNA solution with added ligand (η) using the
flow times of buffer alone (t0) and buffer with DNA plus ligand (tl) and the equation
η = (tl − t0)/t0. Correct the flow times of samples diluted by serial addition of ligand
by multiplying the value by the degree of dilution.
18. Plot (η/η0)1/3, which is the cubed root of the relative viscosity, as a function of the
moles of ligand bound per base pair of DNA (r).
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The latter value is calculated from the binding constant determined in UNIT 8.2. 
See Commentary for a discussion of the interpretation of this plot in terms of intercalation.
An example of such a plot for the binding of ethidium bromide is shown in Figure 8.1.2.
ALTERNATE
PROTOCOL 1
DETERMINATION OF DNA LENGTHENING BY VISCOMETRY FOR
LIGANDS SOLUBLE IN ORGANIC SOLVENTS
DNA-binding ligands are often water insoluble, which necessitates addition of small
amounts of organic solvent to DNA solutions. However, organic solvents significantly
affect the viscosity of the DNA solution. To avoid solvent anomalies, viscosity studies,
in this case, must be performed at a constant concentration of organic solvent and each
ligand concentration must be assessed independent of other concentrations; serial addition
of aliquots of the ligand solution will affect the total solvent concentration and thus the
viscosity. Additionally, some organic solvents have a tendency to produce air bubbles in
aqueous solutions, which will produce anomalous flow times. This problem is solved by
degassing the solutions prior to viscometric studies; volatile solvents should be added
after the buffer is degassed.
Additional Materials (also see Basic Protocol 1)
Ligand of interest dissolved in an organic solvent that is miscible with water
Organic solvent
Microcentrifuge tubes
Small vacuum desiccator with water aspirator
Micro stir bars to fit in microcentrifuge tubes
Magnetic stirring plate
Degas solutions
1. In microcentrifuge tubes, prepare 1-mL solutions of buffer, DNA, and DNA with each
concentration of ligand to be tested, making sure that each solution has the same final
concentration of organic solvent.
Figure 8.1.2 Viscometry data for ethidium bromide binding to sonicated calf thymus DNA.
According to the theory of Cohen and Eisenberg (1969), a plot of the cubed root of the specific
relative viscosity versus r should yield a slope of 1 for a classical intercalator. The slope of 1.07
determined for ethidium bromide is in reasonable agreement with this value.
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If a volatile solvent must be used, degas the aqueous solutions first (steps 1 to 3) and then
add solvent (with or without ligand) after degassing.
The solvent concentration should be the same as that used in the determination of the DNA
binding constant for the ligand (UNIT 8.2). This permits calculation of the proportion of
DNA-bound ligand during the viscosity measurements. In addition, the DNA and organic
solvent concentrations in the samples must be carefully controlled to ensure meaningful
results. This can be accomplished by preparing one large DNA stock solution and dividing
it into aliquots for each ligand concentration, followed by addition of ligand in solvent.
Positive-displacement pipettors can be used to ensure that precise quantities of organic
solvent are delivered to the solutions.
2. Place a micro stir bar in each tube and place the tubes, with lids open, upright in a
small beaker with a piece of tissue to support the tubes.
3. Place the beaker in a vacuum desiccator atop a magnetic stirring plate and, while
stirring, apply a vacuum for 5 to 10 min.
A water aspirator will supply adequate vacuum to degas the solutions. The solutions must
be stirred to prevent bumping of the contents during evacuation.
Determine flow times and analyze the viscosity data
4. Optimize flow times for the DNA solution without ligand as described (see Basic
Protocol 1, steps 6 to 9).
5. Determine flow times of buffer, DNA alone, and DNA with ligand as described (see
Basic Protocol 1, steps 1 to 5 and 10 to 15), but replace each solution with the next
higher ligand concentration instead of adding additional ligand to increase the
concentration.
There is likely to be greater scatter in the viscosity data with this protocol due to the
necessity of using separate DNA solutions for each ligand concentration. This problem is
controlled by performing multiple determinations for each ligand concentration.
6. Calculate relative viscosities as described (see Basic Protocol 1, steps 16 to 18).
BASIC
PROTOCOL 2
ASSESSMENT OF DNA UNWINDING BY PLASMID VISCOMETRY
The second hallmark of intercalation is unwinding of the DNA helix to accommodate the
intercalating ligand. Among the several techniques available to assess helical unwinding,
plasmid viscometry is perhaps the easiest. The technique is based on changes in DNA
topology, and thus the viscosity of the DNA solution, when an intercalator binds to closed
circular plasmid DNA. Knowledge of the DNA binding constant (UNIT 8.2) under the
conditions of the plasmid viscometry allows direct calculation of the angle of unwinding
for each bound intercalator. The unwinding angle can also be calculated by comparison
to ethidium bromide without knowledge of the binding constant. Both analyses are
described below. Additionally, the same binding constant can be applied to all of the
studies in this unit if identical buffer, solvent, and temperature conditions are employed.
Materials
DNA: Phage DNA M13mp, PM2, or ∅X174; plasmids COL E1 or pBR325; or
any similarly sized plasmid (5 to 7 kbp); each prepared by standard alkaline
lysis (e.g., CPMB UNIT 1.7) or similar procedures, and suspended at 1 mg/mL in TE
(APPENDIX 2A) or other buffer
10 mM buffer (Tris⋅Cl, HEPES, or other buffer) containing 1 mM EDTA, pH 7
(for TE buffer see APPENDIX 2A)
Ligand of interest dissolved in above buffer (~1 mM)
1 to 2 mM ethidium bromide solution (see recipe) 
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Semi-micro capillary viscometer (Cannon-Ubehold or Cannon-Manning
semi-micro type 75, see Fig. 8.1.1) 
0.4-µm membrane filtration apparatus (e.g., Millipore Ultrafree MC or Centricon
filters)
Constant-temperature water bath, 25° ± 0.1°C
Stopwatch (± 0.01 sec) or Wescan fiber-optic detection unit and timer (Wescan
Instruments)
Micropipettor with extension or extended microsyringe assembly (Hamilton or
Stoelting)
CAUTION: Ethidium bromide is a mutagen and an environmental hazard. It should be
handled carefully with gloves and disposed of properly. Methods of disposal may vary
between institutions. Consult with the institution’s environmental safety office for the
preferred means of storage and disposal of ethidium bromide.
Determine flow times
1. Determine the average flow time for a 1-mL solution of DNA at a concentration of
0.1 to 0.6 mM nucleotides (30 to 200 µg/mL) as described (see Basic Protocol 1,
steps 6 to 11).
The choice of DNA concentrations depends on the dissociation constant of the ligand. For
dissociation constants in the micromolar range, a DNA concentration 0.2 to 0.6 mM
(nucleotides) ensures virtually complete binding of the ligand, thus obviating the need to
determine the quantity of free and bound ligand.
2. Add the ligand to the DNA solution in the viscometer in 5- to 10-µL increments and
mix the solution by repeated pipetting or by bubbling nitrogen through the solution.
The incremental addition of ligand to the DNA solution will produce minor alterations in
the viscosity of the solution compared to the changes in DNA topology caused by ligand
binding. However, the dilution must be accounted for in the calculation of the unwinding
angle, which are based on actual ligand and DNA concentrations.
3. Following temperature equilibration, determine the average flow time (see Basic
Protocol 1, steps 2 to 4) of the solution for each addition of ligand.
Additions of ligand should continue well past the point at which the viscosity reaches a
maximum; this indicates complete relaxation of the supercoiled plasmid. Further addition
of the intercalating ligand should result in positive supercoiling and a reduction in viscosity.
If there is a bell-shaped dependence of viscosity (flow time) on ligand concentration, then
the ligand may be assumed to cause unwinding of the DNA helix.
If no change in viscosity is observed after ten aliquots of ligand are added, then the ligand
either binds with low affinity or with a small unwinding angle (i.e., DNA unwinding is
minimal); or, less likely, binds with very high affinity or with a very large unwinding angle
(i.e., the first aliquot of ligand produced maximal positive supercoiling).  To overcome this
problem, increase (or decrease) the ligand concentration 5-fold and repeat steps 1-3 until
a bell-shaped curve is obtained.
Determine the unwinding angle
With prior knowledge of the binding constant:
4a. Repeat the flow-time determinations for a serial addition of ethidium bromide to a
fresh 1-mL DNA solution and determine the concentration of ethidium bromide that
produces maximal relaxation of the plasmid DNA (maximal flow time).
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Ethidium bromide serves as a standard for helical unwinding, with each bound molecule
unwinding the helix by ∼26°. As a starting point, ethidium bromide should produce full
relaxation and positive supercoiling over a concentration range of 10 to 40 µM with a 6-
to 7-kbp negatively supercoiled plasmid at ∼0.3 mM base pairs concentration.
5a. Calculate the molar binding ratio (ν; moles of bound ligand per mole of nucleotides)
under conditions of maximal relaxation for both ethidium bromide and ligand.
Calculate the concentration of bound ligand using the binding constant and equation
for the neighbor exclusion model discussed in UNIT 8.2.
6a. Calculate the unwinding angle (relative to ethidium bromide) from the equation ∅L
= ∅Et(νEt/νL), where ∅L is the unwinding angle for the ligand, ∅Et is the known 26°
unwinding angle for ethidium bromide, and νEt and νL are the molar binding ratios
for ethidium bromide and ligand, respectively, at concentrations producing maximal
plasmid relaxation.
Without prior knowledge of the binding constant:
4b. Determine the concentration of ethidium bromide and ligand that produce maximal
relaxation (maximal flow times) for four to five different DNA concentrations
covering a four- to five-fold range (e.g., 0.5 to 2.5 mM nucleotides).
5b. Plot the total concentration of ligand (CT) versus the total DNA concentration (NT)
according to the equation CT = νNT + CF, where the slope (ν) is the molar binding
ratio (moles of ligand bound per mole of nucleotides) and the y intercept (CF) is the
concentration of free ligand.
6b. Calculate the unwinding angle (relative to ethidium bromide) from the equation: ∅L
= ∅Et(νEt/νL), where ∅L is the unwinding angle for the ligand, ∅Et is the known 26°
unwinding angle for ethidium bromide, and νEt and νL are the molar binding ratios
determined from the slopes of the plots in step 5b.
ALTERNATE
PROTOCOL 2
ASSESSMENT OF DNA UNWINDING BY PLASMID VISCOMETRY FOR
LIGANDS SOLUBLE IN ORGANIC SOLVENTS
The problems associated with studying ligands in the presence of organic solvents are
identical to those discussed in Alternate Protocol 1 for DNA lengthening determined by
viscometry. To avoid changes in organic solvent concentration associated with incre-
mental addition of a ligand dissolved in the solvent, the viscosity studies must be
performed at a constant concentration of organic solvent and each ligand concentration
must be assessed independent of other concentrations. The materials and procedures for
plasmid viscometric studies with ligands in organic solvent are exactly as described
earlier. The flow time for each ligand concentration must be determined in a fresh DNA
solution. Large quantities of DNA (∼10 mg) are required for determination of the
unwinding angle if the binding constant is not known because of the need to perform
flow-time determinations for five to ten ligand and ethidium bromide concentrations at
four to five different DNA concentrations.
BASIC
PROTOCOL 3
ASSESSMENT OF CHANGES IN THE OPTICAL PROPERTIES OF
LIGANDS UPON BINDING TO DNA
The third criterion for intercalative DNA binding is a change in the optical properties of
the DNA-bound chromophore. The UV/visible absorbance of classical DNA intercalators
is typically reduced by 40% to 60% when the chromophore inserts between DNA base
pairs. Furthermore, there is often a shift in the absorbance maximum to longer wave-
lengths (i.e., a red shift) as the chromophore interacts with adjacent DNA bases. The
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following protocol assumes that the molar extinction (i.e., extinction coefficient) for the
ligand can be determined and that the absorbance maximum (λmax) of the ligand is
significantly different from that of DNA (>300 nm).
Materials
Sonicated, S1 nuclease–treated calf thymus DNA (see Support Protocol)
10 mM buffer (Tris⋅Cl, HEPES, or other buffer) containing 1 mM EDTA, pH 7
(for TE buffer see APPENDIX 2A)
Ligand of interest dissolved in above buffer
Digital or double-beam UV/visible spectrophotometer capable of recording
absorbance spectra
Determine extinction coefficient of ligand in the absence of DNA
1. Prepare five 1-mL solutions of ligand at 1, 3, 10, 30, and 100 µM in the desired buffer.
Since the molar extinction varies as a function of factors such as ionic strength and pH,
these studies should be performed in the same buffer used in the viscometric studies and
in the binding constant studies described in UNIT 8.2.
The wide range of ligand concentrations ensures that several concentrations will produce
an absorbance value between 0.01 and 1 absorbance unit (AU).
2. Blank a spectrophotometer against the buffer either digitally or by placing the buffer
in one of the compartments of a double-beam instrument.
3. Place a cuvette containing the first ligand solution into the spectrophotometer and
record the spectrum from 200 to 800 nm.
4. Record spectra for each of the ligand concentrations.
5. For spectra containing absorbance peaks in the range of 0.01 to 1 AU, note the
wavelength and exact absorbance for a major peak or shoulder that lies above the
absorbance of DNA (>300 nm).
6. Calculate the extinction coefficient (ε) at this wavelength from the Beer-Lambert law:
A = εlc, where A is the absorbance value, l is the cuvette path length in cm, and c is
the molar ligand concentration.
The extinction coefficient is valid only under the conditions used in its determination (e.g.,
buffer type, pH, ionic strength, temperature, and so on). The coefficient should be calculated
from triplicate determinations of at least three different concentrations.
Determine extinction coefficient of ligand in the presence of DNA
7. Prepare four solutions each containing (1) a ligand concentration that will produce
an absorbance of ∼0.2 to 0.3 and (2) a DNA concentration (nucleotides) that is 3-,
10-, 30-, and 100-fold greater than the ligand concentration. Also prepare the same
DNA solutions without ligand.
It is important to use S1 nuclease–treated DNA to avoid possible problems with spectral
changes upon binding to single-stranded DNA.
8. Blank the spectrophotometer against one of the DNA solutions without ligand.
9. Record the absorbance spectrum of the ligand-containing solution with the same
DNA concentration.
10. Repeat steps 8 and 9 for the other DNA concentrations.
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11. At the wavelength used for determining the extinction coefficient of unbound ligand
in step 6, plot the absorbance for each ligand-containing solution versus the DNA
concentration (in nucleotides) and determine the minimum absorbance value. 
As the DNA concentration increases, the ligand absorbance should decrease to a minimum
value indicative of complete ligand binding. There should be at least two DNA concentra-
tions that produce the minimum absorbance value. If not, repeat steps 8 and 9 with a higher
DNA concentration.
12. Use the minimum absorbance value to calculate the extinction coefficient for the
DNA-bound ligand, as in step 6. 
For a ligand with an association constant greater than ~104 M–1, a 100-fold excess of DNA
should result in the minimum absorbance indicative of complete ligand binding
Determine change in absorbance with DNA
13. Calculate the ratio of extinction coefficients in the absence and presence of DNA.
A classical intercalator will typically experience a 40% to 60% reduction in absorbance
upon binding to DNA.
A shift in absorbance maximum of the ligand upon binding to DNA can be calculated by
obtaining the absorbance spectrum of the ligand without DNA and in the presence of
enough DNA to cause complete binding of the ligand.
SUPPORT
PROTOCOL
PREPARATION OF GENOMIC DNA FRAGMENTS FOR VISCOMETRY
To avoid possible complications from ligand-induced changes in DNA flexibility, the
viscometry studies in Basic Protocol 1 and Alternate Protocol 1 should be performed with
DNA fragments roughly 200 to 250 bp long. DNA of this length can be prepared by
sonication of calf thymus DNA and size fractionation by gel-filtration chromatography.
This protocol is also used to prepare DNA needed for the optical studies in Basic Protocol
3.
Materials
Calf thymus DNA (sodium salt)
Phosphate/EDTA buffer: 50 mM sodium phosphate with 1 mM EDTA, pH 7
Nitrogen gas
Gel loading buffer (APPENDIX 2A)
1% (w/v) agarose gel in TBE buffer
TBE buffer (APPENDIX 2A)
DNA size markers, 100 to 1000 bp (e.g., HaeIII-digested ∅X174 DNA)
10 mM sodium acetate, pH 5/100 mM NaCl/30 µM ZnCl2
S1 nuclease
Buffered phenol or 1:1 (v/v) phenol/chloroform (APPENDIX 2A)
3 M sodium acetate, pH 7
100%, 95%, and 70% (v/v) ethanol
TE buffer, pH 7.5 (APPENDIX 2A)
10 mg/mL DNase-free RNase A (see recipe)
20 mg/mL proteinase K in water (store in single-use aliquots at −20°C)
24:1 (v/v) chloroform/isoamyl alcohol
1 µg/mL ethidium bromide solution (see recipe)
Sonicator (e.g., Branson model 450)
3000- to 10,000-MWCO dialysis tubing
3 × 60–cm column of Sepharose 4B or Sephacryl C-500-HR
Current Protocols in Nucleic Acid Chemistry
8.1.9
Nucleic Acid
Binding Molecules
UV transilluminator
Additional reagents and equipment for agarose gel electrophoresis (e.g., CPMB UNIT
2.5A) and phenol/chloroform extraction (APPENDIX 2A)
Sonicate DNA to produce short fragments
1. Dissolve 100 mg calf thymus DNA in 50 mL phosphate/EDTA buffer by stirring
overnight at 4°C.
2. Place the beaker containing the DNA solution on ice and gently bubble nitrogen
through the solution for 5 min to remove oxygen.
The presence of nitrogen and removal of oxygen reduces the size of DNA fragments
generated in subsequent sonication.
For lengthening/unwinding studies:
3. Sonicate the DNA for a total of 30 min in 5-min intervals at full power using the
0.5-in. end of a disrupter horn (for a Branson model 450 or similar sonicator) with
5-min cooling periods between sonication periods. Gently bubble nitrogen through
the solution during the cooling periods to remove oxygen.
For smaller volume (<50 mL), a microprobe sonicator tip can be used. However, to avoid
damage to the probe, the energy setting must be reduced according to the manufacturer’s
specifications.
For the spectral studies of Basic Protocol 3, sonicate as in step 3 but reduce the time from
30 min to 10 to 15 min and proceed with step 6.
4. Assess the size of DNA fragments by removing 1 µg of DNA from the sonication
mixture, mixing with gel loading buffer, and resolving the DNA on a 1% agarose gel
in TBE buffer until the bromophenol blue dye has migrated approximately one-half
the length of the gel. Include a lane of DNA size markers covering the range of 100
to 1000 bp.
This ensures that an adequate quantity of 200- to 250-bp DNA fragments is present in the
mixture of sheared DNA fragments.
5. If the fragment sizes are too large, sonicate the mixture for another 10 to 15 min and
repeat the gel analysis.
Remove single-stranded DNA:
6. Dialyze the DNA three times against 4 L (each time) of 10 mM sodium acetate, pH
5/100 mM NaCl/30 µM ZnCl2 at 4°C. Use 3000- to 10,000-MWCO dialysis tubing
and perform at least one of the dialysis steps overnight.
7. Digest the single-stranded DNA with S1 nuclease (20 IU) 1 hr at 37 °C. Extract the
DNA several times with phenol and chloroform (see APPENDIX 2A).
8. Add 3 M sodium acetate to 0.3 M and 2 vol of 100% ethanol to precipitate. Centrifuge
15 min at 16,000 × g. Wash the DNA twice with 70% ethanol and once with 95%
ethanol.
9. Dry the DNA either by vacuum centrifugation or by overnight evaporation on a bench
top. Redissolve the dried DNA pellet in 50 mL TE buffer and proceed with step 7.
The dialysis can be performed after the sonication step.
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Purify DNA
10. Remove the DNA from the dialysis tubing and add sodium acetate to 300 mM
followed by DNase-free RNase to 0.1 mg/mL. Incubate 1 hr at 37°C.
11. Add proteinase K to 0.1 mg/mL and incubate 2 hr at 37°C.
12. Extract the solution four times with an equal volume of buffered phenol or 1:1 (v/v)
phenol/chloroform to remove proteins (APPENDIX 2A), and twice with 24:1 (v/v)
chloroform/isoamyl alcohol to remove residual phenol.
13. Precipitate the DNA by adding 2 vol of 100% ethanol and centrifuging 15 min at
16,000 × g, 4°C.
14. Wash the DNA twice with 70% ethanol and once with 95% ethanol. Dry the DNA
either by vacuum centrifugation or by overnight evaporation on a bench top.
Size fractionate DNA
15. Redissolve the DNA in phosphate/EDTA buffer at 4 mg/mL and apply half the
solution to a 3 × 60–cm Sepharose 4B or Sephacryl S-500-HR gel-filtration column
to resolve the DNA fragments by size.
The other half of the DNA solution can be stored at −20°C for later chromatographic
purification.
The most convenient means to monitor the elution of DNA from the column is to use a
complete liquid chromatographic system with a peristaltic pump, UV detector (254 nm),
chart recorder, and fraction collector.
16. Mix a 5- to 10-µL aliquot of each fraction with gel loading buffer and resolve the
DNA on a 1% agarose gel as in step 4a.
The aliquot should contain 50 to 300 ng of DNA based on absorbance at 260 nm, assuming
that 1 A260 = 50 µg/mL DNA.
17. Stain the gel with 1 µg/mL ethidium bromide solution and visualize the DNA
fragments by UV illumination.
CAUTION: Ethidium bromide is a mutagen and environmental hazard. It should be handled
carefully with gloves and disposed of properly. Methods of disposal may vary between
institutions. Consult with the institution’s environmental safety office for the preferred
means of storage and disposal.
18. Identify the fractions containing DNA with an average size of ∼200 bp, pool these
fractions, and dialyze the solution three times against 4 L of TE buffer at 4°C with
at least one overnight dialysis step.
19. Add 0.1 vol of 3 M sodium acetate and precipitate the DNA with 2 vol of 100%
ethanol by centrifuging 30 min at 16,000 × g, 4°C.
20. Wash and dry the pellet as in step 14.
21. Dissolve the DNA in the desired buffer (see Basic Protocol 1 and Basic Protocol 3)
at 3 mg/mL and store at −20°C.
The DNA can be stored several months at –20°C. If the DNA is to be kept for long periods,
it can be stored in screw-cap tubes at –80°C for at least a year.
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REAGENTS AND SOLUTIONS
Use deionized water in all recipes and protocol steps. For common stock solutions, see APPENDIX 2A;
for suppliers, see SUPPLIERS APPENDIX.
DNase-free RNase A, 10 mg/mL
Dissolve DNase-free RNase A in TE buffer (APPENDIX 2A) at 1 mg/mL and boil 10 to
30 min. Store in aliquots at −20°C to prevent microbial growth. For additional details
on this enzyme, see CPMB UNIT 3.13.
Ethidium bromide solution, 1 to 10 mg/mL
Prepare a 1 to 10 mg/mL stock solution of ethidium bromide in water. Determine
the exact concentration of ethidium bromide in this crude stock by measuring its
absorbance at 480 nm and using the molar extinction coefficient (ε480) = 5600
M−1cm−1. Store for up to 6 months at 4°C protected from light. For assessment of
DNA unwinding (see Basic Protocol 2), dilute stock to 1 to 2 mM in the desired
buffer. For staining agarose gels (see Support Protocol), dilute to 1 µg/mL in TBE
buffer (APPENDIX 2A).
COMMENTARY
Background Information
The three sets of experiments presented in
this unit are designed to define the ability of a
DNA-binding ligand to intercalate between the
base pairs of DNA. If a ligand increases the
viscosity of a solution of linear DNA fragments
(Lerman, 1961; Waring, 1970), produces a bell-
shaped viscosity profile with plasmid DNA
(Révet et al., 1971), and undergoes DNA-in-
duced quenching of its absorbance, then it can
be presumed to bind to DNA by intercalation.
Alone, the individual observations are insuffi-
cient to establish intercalation since there are
exceptions to each. For example, cisplatin, a
DNA cross-linker that binds to the N7 position
of guanine, and irehdiamine, a steroidal
groove-binder, both unwind supercoiled plas-
mid DNA (Saucier 1977; Cohen et al., 1979),
but neither causes an increase in the viscosity
of a DNA solution. The reader is referred to the
work of Satyanarayana et al. (1993) for a rig-
orous comparison of the viscometric and spec-
tral behaviors of several groove binders and
intercalators. This biophysical evidence for in-
tercalation is best corroborated by NMR or
X-ray crystallographic studies.
Critical Parameters
Several parameters must be controlled to
avoid erroneous results. First, the viscometer
should be cleaned after each use by overnight
soaking in 10% to 50% nitric acid, followed by
thorough rinsing with deionized water and dry-
ing. Particulate matter present in all of the
solutions should be removed by filtration
through a ≥0.4-µm filter.
Second, the temperature, ionic composition,
pH, and concentration of organic solvents must
be precisely controlled in viscosity studies.
Small changes in organic solvent concentra-
tion, for example, can significantly alter flow
times in the viscometer. These same conditions
must be employed for the determination of
binding constants discussed in UNIT 8.2, since the
thermodynamics of ligand binding vary ac-
cording to the properties of the solution.
Third, it is important to check for changes
in flow time of the buffer and control DNA
solutions regularly throughout the viscometric
studies. This ensures that there are no anomalies
caused by residual solvents or components
sticking to the walls of the viscometer capillary.
Finally, the length of the linear DNA frag-
ments must be short enough to avoid problems
arising from ligand-induced changes in the
flexibility of the DNA. The use of ∼200-bp
DNA fragments, roughly the persistence length
of DNA, prevents problems with flexibility.
Significantly shorter fragments (<50 bp) will
produce unacceptably short flow times.
Troubleshooting
The most likely cause of highly variable
flow times is a dirty or clogged viscometer.
Regular cleaning of the viscometer and filtra-
tion of the solutions will prevent this problem.
The presence of small air bubbles in the vis-
cometer capillary can be avoided by degassing
the solutions, especially those containing non-
volatile organic solvents. Care must be taken to
avoid precipitation of the DNA fragments that
can be caused by extremely high concentrations
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of some ligands as indicated by visible precipi-
tates or a sudden decrease in flow time. Fur-
thermore, high concentrations of water-insol-
uble ligands can result in aggregation and pre-
cipitation of the ligand, which may also create
problems. One way to check for viscosity
changes due to ligand insolubility is to perform
flow-time measurements with high concentra-
tions of the ligand in buffer alone.
Although flow times will depend on the type
of viscometer used, excessively long flow times
(>180 sec) can be avoided by reducing the DNA
concentration.
Anticipated Results
The results of the plasmid viscosity experi-
ments are self explanatory: if the viscosity of
the DNA solution increases and then decreases
in a bell-shaped curve as a function of ligand
concentration, then the ligand can be presumed
to unwind the DNA helix. For the DNA length-
ening studies, the theory of Cohen and Eisen-
berg (1969) predicts that a plot of (η/η0)1/3
versus r (moles of ligand bound per mole of
DNA base pairs) will give a slope ≈ 1 for a
“classical” intercalator (for example, see Fig.
8.1.2). This result is based on the predicted
3.4-Å increase in the length of the DNA helix
when an intercalator is positioned between
DNA base pairs. Most classical intercalators
produce a slope lying between 0.5 and 1 in such
a plot (Wilson and Jones, 1982), while “classi-
cal” groove binders such as Hoechst 33258
produce a slope of zero (Satyanarayana et al.,
1993).
With regard to changes in ligand absorbance
upon binding to DNA, the results can be highly
variable. Classical intercalators, as well as
many groove-binding ligands, will show a re-
duced absorbance of light when bound to DNA.
However, a shift to longer wavelengths does not
always accompany intercalation, as illustrated
by the binding of the intercalating enediyne
esperamicin A1 to DNA (Yu et al., 1994).
Time Considerations
The time to complete the viscosity studies
is highly variable and depends on the number
of ligand concentrations studied, the need for
organic solvents, and the experience of the
researcher. At least 1 week of work should be
anticipated to complete each protocol. Al-
though the preparation of DNA fragments and
plasmid DNA will require additional time, suf-
ficiently large quantities of these reagents can
be prepared at one time for use in many differ-
ent studies.
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